First systematic chemical profiling of cocaine police seizures in Finland in the framework of an intelligence-led approach

Forensic Science International

Volumn 251, Issue , 2015, Pages 87-94

  Broséus, Julian ^a   Huhtala, Sami ^b   Esseiva, Pierre ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b National Bureau of Investigation Finland   (Finland)

Author keywords

Cocaine trafficking; Distribution networks; Illicit drugs; Profiling

Indexed keywords

BENZOYLECGONINE; BETA ALANINE; CAFFEINE; COCAINE; CREATINE; DILTIAZEM; ECGONINE; ECGONINE METHYL ESTER; GLUCOSE; HYDROXYZINE; IBUPROFEN; LACTOSE; LEVAMISOLE; LIDOCAINE; MANNITOL; NORCOCAINE; PARACETAMOL; PHENACETIN; PSEUDOTROPINE BENZOATE; NARCOTIC AGENT;

ARTICLE; CHEMICAL COMPOSITION; DRUG ANALYSIS; DRUG TRAFFIC; FINLAND; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MASS FRAGMENTOGRAPHY; MEASUREMENT ACCURACY; MEASUREMENT ERROR; POLICE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS; CHEMISTRY; DRUG CONTAMINATION; HUMAN;

COCAINE; DRUG CONTAMINATION; DRUG TRAFFICKING; FINLAND; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; NARCOTICS;

EID: 84927672011     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2015.03.026     Document Type: Article

References (27)

1. Reitox National Focal Point T. Finland Drug Situation, in National Report to the EMCDDA 2011.
2. Kankaanpää A., Ariniemi K., Heinonen M., Kuoppasalmi K., Gunnar T. Use of illicit stimulant drugs in Finland: a wastewater study in ten major cities. Sci. Total Environ. 2014, 487(1):696-702.
3. Vuori E., Happonen M., Gergov M., Nenonen T., Järvinen A., Ketola R.A., Vahala R. Wastewater analysis reveals regional variability in exposure to abused drugs and opioids in Finland. Sci. Total Environ. 2014, 487(1):688-695.
4. Collins M., Huttunen J., Evans I., Robertson J. Illicit drug profiling: the Australian experience. Aust. J. Forensic Sci. 2007, 39(1):25-32.
5. Botelho E.D., Cunha R.B., Campos A.F.C., Maldaner A.O. Chemical profiling of cocaine seized by Brazilian federal police in 2009-2012: major components. J. Br. Chem. Soc. 2014, 25(4):611-618.
6. Lociciro S., Hayoz P., Esseiva P., Dujourdy L., Besacier F., Margot P. Cocaine profiling for strategic intelligence purposes, a cross-border project between France and Switzerland: Part I. Optimisation and harmonisation of the profiling method. Forensic Sci. Int. 2007, 167(2-3):220-228.
7. UNODC Drug Characterization/Impurity Profiling, Background and Concepts 2001, United Nations, Vienna. S. Section (Ed.).
8. UNODC Methods for Impurity Profiling of Heroin and Cocaine 2005, United Nations, Vienna. L. Section (Ed.).
9. Morelato M., Beavis A., Tahtouh M., Ribaux O., Kirkbride P., Roux C. The use of forensic case data in intelligence-led policing: the example of drug profiling. Forensic Sci. Int. 2013, 226(1-3):1-9.
10. Ioset S., Esseiva P., Ribaux O., Weyermann C., Anglada F., Lociciro S., Hayoz P., Baer I., Gasté L., Terrettaz-Zufferey A.L., Delaporte C., Margot P. Establishment of an operational system for drug profiling: a Swiss experience. Bull. Narcotics 2007, 57(1-2):121-147.
11. Esseiva P., Ioset S., Anglada F., Gaste L., Ribaux O., Margot P., Gallusser A., Biedermann A., Specht Y., Ottinger E. Forensic drug Intelligence: an important tool in law enforcement. Forensic Sci. Int. 2007, 167(2-3):247-254.
12. Gentile N., Esseiva P., Besacier F., Jalava K., Van Durme F. Drug Profiling: Methodology and Exploitation, in ENFSI Drug Working Group 2013, Dubrovnik.
13. Gentile N., Besson L., Pazos D., Delémont O., Esseiva P. On the use of IRMS in forensic science: proposals for a methodological approach. Forensic Sci. Int. 2011, 212(1-3):260-271.
14. Esseiva P., Margot P. Drug Profiling, in Wiley Encyclopedia of Forensic Science 2009, John Wiley & Sons Ltd.
15. Ribaux O., Baylon A., Roux C., Delémont O., Lock E., Zingg C., Margot P. Intelligence-led crime scene processing Part I: Forensic intelligence. Forensic Sci. Int. 2010, 195(1-3):10-16.
16. Ribaux O., Walsh S.J., Margot P. The contribution of forensic science to crime analysis and investigation: forensic intelligence. Forensic Sci. Int. 2006, 156(2-3):171-181.
17. Esseiva P., Gaste L., Alvarez D., Anglada F. Illicit drug profiling, reflection on statistical comparisons. Forensic Sci. Int. 2011, 207(1-3):27-34.
18. Lociciro S., Esseiva P., Hayoz P., Dujourdy L., Besacier F., Margot P. Cocaine profiling for strategic intelligence, a cross-border project between France and Switzerland: Part II. Validation of the statistical methodology for the profiling of cocaine. Forensic Sci. Int. 2008, 177(2-3):199-206.
19. Funk W., Dammann V., Donnevert G. Quality Assurance in Analytical Chemistry 2007, Wiley-VCH Verlag GmbH & Co KGaA.
20. International Conference on Harmonization (ICH) Validation of Analytical Methods: Methodology 1996, ICH Q2 B.
21. Broséus J., Debrus B., Delémont O., Rudaz S., Esseiva P. Study of common database feeding with results coming from different analytical methods in the framework of illicit drugs chemical profiling. Forensic Sci. Int. 2013, 230(1-3):16-28.
22. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics: Part A Data handling in science and technology, vol. 20A 1997, Elsevier, Amsterdam.
23. EMCDDA. Purity of Cocaine at Retail Level. European Monitoring Centre for Drugs and Drug Addiction 2013, Available from: http://www.emcdda.europa.eu/stats13 - display:/stats13/ppptab7a.
24. Cole C., Jones L., McVeigh J., Kicman A., Syed Q., Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test. Anal. 2011, 3(2):89-96.
25. Cole C., Jones L., McVeigh J., Kicman A., Syed Q., Bellis M.A. CUT A Guide to Adulterants Bulking Agents and Other Contaminants Found in Illicit Drugs 2010, Liverpool John Moores University, Liverpool.
26. Decorte T. Quality control by cocaine users: underdeveloped harm reduction strategies. Eur. Addict. Res. 2001, 7(4):161-175.
27. Evrard I., Legleye S., Cadet-Taïrou A. Composition, purity and perceived quality of street cocaine in France. Int. J. Drug Pol. 2010, 21(5):399-406.